COVID-19 in tralokinumab-treated patients with moderate-to- severe atopic dermatitis: case series from the ECZTEND long- term extension trial. (2021). SKIN The Journal of Cutaneous Medicine, 5(6), s58. https://doi.org/10.25251/skin.5.supp.58